We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDXS icon
726
Codexis
CDXS
$136M
$741K 0.01%
158,975
+16,022
+11% +$87.8K
BBIO icon
727
BridgeBio Pharma
BBIO
$16.8B
$733K ﹤0.01%
96,244
+469
+0.5% +$4.49K
PETQ
728
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$732K ﹤0.01%
79,346
-31,656
-29% -$296K
RDY icon
729
Dr. Reddy's Laboratories
RDY
$9.77B
$724K ﹤0.01%
+70,000
New +$755K
PBA icon
730
Pembina Pipeline
PBA
$29B
$720K ﹤0.01%
21,236
-1,377
-6% -$46.2K
NEO icon
731
NeoGenomics
NEO
$1.74B
$710K ﹤0.01%
76,879
-21,437
-22% -$200K
APA icon
732
APA Corp
APA
$12.3B
$709K ﹤0.01%
15,184
– –
MTN icon
733
Vail Resorts
MTN
$5.6B
$705K ﹤0.01%
2,956
-622
-17% -$146K
JNPR
734
DELISTED
Juniper Networks
JNPR
$695K ﹤0.01%
21,758
-4,829
-18% -$146K
WPM icon
735
Wheaton Precious Metals
WPM
$49.8B
$692K ﹤0.01%
17,716
-201
-1% -$7.27K
DPZ icon
736
Domino's
DPZ
$11.6B
$684K ﹤0.01%
1,974
+54
+3% +$18.9K
VTRS icon
737
Viatris
VTRS
$20.8B
$677K ﹤0.01%
60,825
-9,675
-14% -$101K
NVTA
738
DELISTED
Invitae Corporation
NVTA
$676K ﹤0.01%
363,371
+14,276
+4% +$34.9K
ENTG icon
739
Entegris
ENTG
$18B
$659K ﹤0.01%
10,047
-2,194
-18% -$162K
MYGN icon
740
Myriad Genetics
MYGN
$502M
$659K ﹤0.01%
45,398
+1,241
+3% +$23.1K
SIRI icon
741
SiriusXM
SIRI
$10.7B
$658K ﹤0.01%
11,267
-6,047
-35% -$372K
ROKU icon
742
Roku
ROKU
$21.3B
$651K ﹤0.01%
15,985
-10,780
-40% -$563K
LII icon
743
Lennox International
LII
$18.9B
$649K ﹤0.01%
2,711
-10,241
-79% -$2.51M
AMH icon
744
American Homes 4 Rent
AMH
$12.2B
$636K ﹤0.01%
21,107
-4,640
-18% -$147K
SU icon
745
Suncor Energy
SU
$75.4B
$634K ﹤0.01%
20,002
– –
TRP icon
746
TC Energy
TRP
$70.5B
$633K ﹤0.01%
15,892
-2,942
-16% -$128K
ATRA icon
747
Atara Biotherapeutics
ATRA
$70.4M
$627K ﹤0.01%
7,642
-1,342
-15% -$140K
HEI.A icon
748
HEICO Corp Class A
HEI.A
$36.8B
$624K ﹤0.01%
5,210
-3,592
-41% -$438K
EQT icon
749
EQT Corp
EQT
$32.3B
$613K ﹤0.01%
18,132
-2,916
-14% -$117K
WHR icon
750
Whirlpool
WHR
$2.49B
$610K ﹤0.01%
4,309
-302
-7% -$42.9K
28 29
30
31 32

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.